Latest Regulatory Approvals News

Archer Materials has made significant strides in its quantum computing and medical diagnostics programs, including improved carbon qubit readout and clinical-standard silicon biochips, while securing key partnerships and maintaining a strong cash position.

Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.

CurveBeam AI reported steady progress in Q2 FY26 with five new device purchase orders, a $4 million milestone payment pending receipt, and key regulatory submissions underway in the US and China.

Arovella Therapeutics has secured a crucial regulatory nod from the U.S. FDA, allowing its lead CAR-iNKT cell therapy, ALA-101, to enter first-in-human clinical trials targeting blood cancers.

Silver Mines Limited has reported its best-ever drilling results at the Bowdens Silver Project in NSW while navigating a complex regulatory redetermination process. Exploration advances continue across its Australian and US projects, supported by a strong cash position.

Ragusa Minerals has executed a binding agreement to acquire a majority interest in the Purple Pansy manganese-gold project in Arizona, expanding its landholding and raising $600,000 to fund exploration.

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its NorthStar Mapping System, the first MRI-native 3D cardiac mapping platform approved in the US. This approval positions Imricor at the forefront of MRI-guided cardiac procedures in the world’s largest electrophysiology market.

Maronan Metals has secured crucial environmental approvals and completed promising drilling and metallurgical work, underpinned by a strong capital raise and rising silver prices.

Great Divide Mining has resolved a key joint venture dispute to move towards 100% ownership of the Challenger Gold Mine, while progressing promising exploration results and joint ventures across its Queensland and New South Wales projects.

Nico Resources has progressed key development activities at its Wingellina nickel-cobalt project, preparing for an infill drilling campaign as nickel and cobalt prices rally on Indonesian supply policy shifts.

Bayan Mining and Minerals Limited has secured exclusive rights to advanced rare earth processing technologies and made significant progress on its US exploration projects, setting the stage for maiden drilling in 2026.